The financial markets are signaling a remarkably bullish outlook, with both stock and bond markets fully embracing a “run it hot” trade. However, this aggressive market pricing stands in stark contrast to the pessimistic views held by bottom-up analysts, companies, and economists, according to a recent analysis by Bob Elliott, CIO at Unlimited Funds.
What Happened: Elliott, in a detailed X thread, highlights this unprecedented “divergence” which he has “never seen” in his professional career outside of typical cyclical bottoms.
Don't Miss:
- Start investing with eToro's CopyTrader — mirror top-performing traders with no management fees, and receive a $10 bonus when you deposit $100 today.
- Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today.
Following Tuesday’s surge in the equity market, market-based pricing of growth expectations has almost entirely recovered its earlier drop this year, now sitting just a few points off highs.
As highlighted by Elliott, this sentiment is reflected in large-cap 12-month forward price-to-earnings ratios, which are back near all-time highs at 21x.
Concurrently, long-dated real yields have reached their post-COVID cycle highs, and term premiums on closer-in maturities are also approaching their cycle peaks.
Despite this seemingly extreme market optimism, the perspective from professionals analyzing data from the ground up paints a far more subdued picture. Economists are forecasting softer growth for the next couple of years.
Corporate earnings revisions for U.S. large-cap companies have notably collapsed, reaching their weakest point since the COVID-19 pandemic. Global earnings revisions also remain quite subdued, despite a marginal recent uptick in negativity.
Projections for 2025 earnings growth, which are typically skewed positively until just before the period, are currently penciled in at a mere 7%.
Why It Matters: According to Elliott, either bottom-up analysts, scrutinizing incoming data, are taking an excessively pessimistic stance, or they are accurate, implying the markets are “wildly offside.”
For macro investors, he suggests, “making a call on which is right will likely be the make or break trade for the rest of ’25.”
Read Next:
- Nancy Pelosi Invested $5 Million In An AI Company Last Year — Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.
- Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.